Risk of COVID-19 for patients with cancer

By Hanping Wang, Li Zhang. The Lancet Oncology, 2020

595 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Infectious Diseases, Oncology

View Paper: https://www.semanticscholar.org/paper/7e5b11cfede3fa76adea9567ebb410e813ee212e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Perez-soler
2. A. Acuna-Villaorduna
3. Li Chai
4. Mauricio Santillana
5. Miao Liu
6. Y. Xiong
7. Zhi-An Zhang
8. H. Xiong

Citations in the corpus

• Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System (2020, background): “(8) Early case series from China and Italy have suggested that patients with malignancy are more susceptible to severe infection and mortality from COVID-19(9-12), a phenomenon that has been noted in other pandemics.”
• Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak (2020, result): “A recent study reported a higher risk of severe events in patients with cancer when compared with patients without cancer (4); however, the small sample size of SARS-CoV-2 patients with cancer used in the study limited how representative it was of the whole population and made it difficult to conduc”